LINC01061: A Potential Drug Target and Biomarker (G401149)

Target Name: LINC01061

NCBI ID: G401149

LINC01061

Other Name(s): Long intergenic non-protein coding RNA 1061 | long intergenic non-protein coding RNA 1061

LINC01061: A Potential Drug Target and Biomarker

Long intergenic non-protein coding RNAs (lncNPs) have emerged as a promising class of non-coding RNAs that can provide valuable insights into gene function and regulation. Among these, LINC01061 is a novel lncNP that has garnered significant interest due to its unique features and potential implications as a drug target or biomarker.

LINC01061 is a 21.1 kilobase (kb) RNA molecule that was identified through high-throughput sequencing (HTS) experiments. It was found to encode a protein-like structure with a predicted molecular weight of 19.9 kDa. LINC01061 is predominantly expressed in the brain and is highly stable in the cell, which are two key factors that are often associated with its potential utility as a drug target or biomarker.

One of the key features of LINC01061 is its expression pattern, which has been extensively characterized using RNA sequencing (RNA-seq) experiments. Research has found that LINC01061 is highly expressed in the brain and is significantly enriched for different brain regions, including the prefrontal cortex , basal ganglia, and cerebellum. Additionally, LINC01061 is also expressed in other tissues and cells, including muscle, liver, and heart, suggesting its potential utility as a biomarker for a variety of biological processes.

Another important property of LINC01061 is its potential to interact with other molecules. LINC01061 was found to interact with several proteins, including the neurotransmitter dopamine, the protein synaptophysin, and the transcription factor PDGF-2. These interactions suggest that LINC01061 may play a role in the regulation of neural circuitry and may be a potential drug target for a variety of neurological and psychiatric disorders.

In addition to its potential utility as a drug target or biomarker, LINC01061 also raises the intriguing possibility of serving as a therapeutic agent for a variety of diseases. Given its unique expression pattern and interaction with other molecules, LINC01061 may be a promising target for small molecule inhibitors that can modulate its activity and improve neuronal function.

In conclusion, LINC01061 is a fascinating lncNP that has the potential to serve as a drug target or biomarker for a variety of neurological and psychiatric disorders. Its unique expression pattern and interaction with other molecules make it an attractive candidate for further study and potential clinical applications . Further research is needed to fully understand the mechanisms of LINC01061's behavior and to explore its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 1061

The "LINC01061 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01061 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets